CN112584828A - 人乳头瘤病毒高危感染的疗法 - Google Patents

人乳头瘤病毒高危感染的疗法 Download PDF

Info

Publication number
CN112584828A
CN112584828A CN201980055480.2A CN201980055480A CN112584828A CN 112584828 A CN112584828 A CN 112584828A CN 201980055480 A CN201980055480 A CN 201980055480A CN 112584828 A CN112584828 A CN 112584828A
Authority
CN
China
Prior art keywords
composition
pharmaceutical composition
use according
acid
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980055480.2A
Other languages
English (en)
Chinese (zh)
Inventor
N·富克斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siro Medical Ltd
Original Assignee
Siro Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siro Medical Ltd filed Critical Siro Medical Ltd
Publication of CN112584828A publication Critical patent/CN112584828A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201980055480.2A 2018-08-28 2019-08-28 人乳头瘤病毒高危感染的疗法 Pending CN112584828A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
EP18191289.0 2018-08-28
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
CN112584828A true CN112584828A (zh) 2021-03-30

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980055480.2A Pending CN112584828A (zh) 2018-08-28 2019-08-28 人乳头瘤病毒高危感染的疗法

Country Status (25)

Country Link
US (2) US20210299163A1 (https=)
EP (2) EP3616693A1 (https=)
JP (1) JP7420791B2 (https=)
CN (1) CN112584828A (https=)
AR (1) AR116027A1 (https=)
AU (1) AU2019332079B2 (https=)
BR (1) BR112021003360A2 (https=)
CA (1) CA3107691C (https=)
CL (1) CL2021000197A1 (https=)
EA (1) EA202190441A1 (https=)
ES (1) ES2958808T3 (https=)
GE (2) GEAP202215586A (https=)
HR (1) HRP20231470T1 (https=)
HU (1) HUE064691T2 (https=)
IL (1) IL281080B2 (https=)
MA (1) MA53482B1 (https=)
MD (1) MD3843715T2 (https=)
MX (1) MX2021002310A (https=)
PL (1) PL3843715T3 (https=)
RS (1) RS64916B1 (https=)
SM (1) SMT202300340T1 (https=)
TW (1) TWI827652B (https=)
UA (1) UA127632C2 (https=)
WO (1) WO2020043762A1 (https=)
ZA (1) ZA202100375B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279358A (zh) * 2020-03-03 2022-11-01 赛罗医学有限公司 用于治疗宫颈细胞异常的包含亚硒酸盐化合物和酸的组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1529606A (zh) * 2001-02-13 2004-09-15 维斯-维塔利斯许可和贸易有限公司 用于治疗创伤的含有亚硒酸盐或硒酸盐的制剂
US20050048134A1 (en) * 2001-12-04 2005-03-03 Bodo Kuklinski Use of selenite-containing compounds to be topically or buccally administered
CN103379899A (zh) * 2011-02-16 2013-10-30 塞罗医疗股份有限公司 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2245301C2 (ru) 2000-05-10 2005-01-27 Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх Способ уменьшения площади поверхности диоксида кремния
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1529606A (zh) * 2001-02-13 2004-09-15 维斯-维塔利斯许可和贸易有限公司 用于治疗创伤的含有亚硒酸盐或硒酸盐的制剂
US20050048134A1 (en) * 2001-12-04 2005-03-03 Bodo Kuklinski Use of selenite-containing compounds to be topically or buccally administered
CN103379899A (zh) * 2011-02-16 2013-10-30 塞罗医疗股份有限公司 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279358A (zh) * 2020-03-03 2022-11-01 赛罗医学有限公司 用于治疗宫颈细胞异常的包含亚硒酸盐化合物和酸的组合物

Also Published As

Publication number Publication date
CA3107691A1 (en) 2020-03-05
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
GEP20227432B (en) 2022-10-25
EA202190441A1 (ru) 2021-06-15
MD3843715T2 (ro) 2023-12-31
AU2019332079B2 (en) 2024-08-29
CA3107691C (en) 2024-10-29
EP3616693A1 (en) 2020-03-04
RS64916B1 (sr) 2023-12-29
IL281080A (en) 2021-04-29
EP3843715A1 (en) 2021-07-07
WO2020043762A1 (en) 2020-03-05
IL281080B1 (en) 2024-08-01
HUE064691T2 (hu) 2024-04-28
US20250281524A1 (en) 2025-09-11
ZA202100375B (en) 2024-08-28
TWI827652B (zh) 2024-01-01
AR116027A1 (es) 2021-03-25
BR112021003360A2 (pt) 2021-05-11
EP3843715B1 (en) 2023-09-13
PL3843715T3 (pl) 2024-02-19
MA53482B1 (fr) 2023-11-30
UA127632C2 (uk) 2023-11-08
MA53482A (fr) 2021-07-07
ES2958808T3 (es) 2024-02-15
MX2021002310A (es) 2021-04-28
IL281080B2 (en) 2024-12-01
US20210299163A1 (en) 2021-09-30
HRP20231470T1 (hr) 2024-03-01
SMT202300340T1 (it) 2023-11-13
EP3843715C0 (en) 2023-09-13
TW202023534A (zh) 2020-07-01
CL2021000197A1 (es) 2021-09-20
AU2019332079A1 (en) 2021-02-11
GEAP202215586A (en) 2022-06-27

Similar Documents

Publication Publication Date Title
EP3603637B1 (en) Treatment of cancer and benign proliferative disorders caused by human papilloma virus
US20250281524A1 (en) Therapy of high-risk human papillomavirus infections
CN107582563B (zh) 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂
ES2976058T3 (es) Composición para su uso en el tratamiento de las anomalías de las células cervicales que comprende compuesto de selenita y ácido
EA042677B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
CA3167015C (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
EA048333B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
HK40045218B (en) Therapy of high-risk human papillomavirus infections
HK40045218A (en) Therapy of high-risk human papillomavirus infections
EA048159B1 (ru) Композиция для применения в лечении аномалий цервикальных клеток, содержащая селенитовое соединение и кислоту
HK40074763B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK40074763A (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination